Regeneron Pharmaceuticals Inc (REGN)
957.00
+19.39
(+2.07%)
USD |
NASDAQ |
May 03, 16:00
956.28
-0.72
(-0.08%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price: 957.00 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 926.94 | 958.13 | 926.94 | 957.00 | 525887.0 |
May 02, 2024 | 900.00 | 943.77 | 891.30 | 937.61 | 1.067M |
May 01, 2024 | 889.41 | 913.21 | 888.52 | 903.48 | 595182.0 |
Apr 30, 2024 | 892.11 | 896.85 | 885.01 | 890.66 | 636697.0 |
Apr 29, 2024 | 883.20 | 897.78 | 883.20 | 892.48 | 369920.0 |
Apr 26, 2024 | 881.72 | 887.48 | 875.22 | 883.20 | 505652.0 |
Apr 25, 2024 | 911.09 | 915.00 | 876.75 | 890.68 | 576565.0 |
Apr 24, 2024 | 906.90 | 915.70 | 904.41 | 906.54 | 373718.0 |
Apr 23, 2024 | 905.66 | 912.74 | 903.83 | 907.32 | 341220.0 |
Apr 22, 2024 | 904.54 | 908.67 | 897.45 | 900.16 | 351366.0 |
Apr 19, 2024 | 913.97 | 920.73 | 891.46 | 896.82 | 507466.0 |
Apr 18, 2024 | 901.26 | 908.81 | 891.67 | 893.99 | 450630.0 |
Apr 17, 2024 | 903.88 | 911.64 | 899.90 | 901.19 | 468668.0 |
Apr 16, 2024 | 897.22 | 901.06 | 890.43 | 894.14 | 615756.0 |
Apr 15, 2024 | 915.37 | 921.12 | 895.09 | 898.56 | 656427.0 |
Apr 12, 2024 | 911.55 | 912.22 | 898.26 | 904.70 | 665281.0 |
Apr 11, 2024 | 928.58 | 930.64 | 907.33 | 920.32 | 617176.0 |
Apr 10, 2024 | 935.02 | 937.87 | 923.44 | 936.20 | 389765.0 |
Apr 09, 2024 | 941.39 | 949.20 | 938.00 | 943.89 | 305901.0 |
Apr 08, 2024 | 939.16 | 942.98 | 935.51 | 938.48 | 330917.0 |
Apr 05, 2024 | 939.31 | 949.83 | 934.87 | 942.70 | 363545.0 |
Apr 04, 2024 | 962.20 | 962.20 | 935.36 | 937.02 | 410837.0 |
Apr 03, 2024 | 955.00 | 961.68 | 950.43 | 950.95 | 413251.0 |
Apr 02, 2024 | 961.44 | 961.44 | 951.02 | 954.68 | 438124.0 |
Apr 01, 2024 | 964.73 | 970.20 | 954.09 | 969.31 | 360696.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
273.46
Minimum
Sep 27 2019
993.35
Maximum
Feb 27 2024
612.53
Average
614.38
Median
Jan 20 2022
Price Benchmarks
Vertex Pharmaceuticals Inc | 401.08 |
Amgen Inc | 311.29 |
Eli Lilly and Co | 734.97 |
Moderna Inc | 125.00 |
Gilead Sciences Inc | 64.78 |
Price Related Metrics
PE Ratio | 28.27 |
PS Ratio | 8.330 |
Price to Book Value | 3.907 |
Price to Free Cash Flow | 27.77 |
Earnings Yield | 3.54% |
Market Cap | 105.45B |
Operating PE Ratio | 27.36 |
Normalized PE Ratio | 26.11 |